Last reviewed · How we verify
Bacterial Corneal Ulcer Infection
Approved treatments
- Ciprofloxacine · Poitiers University Hospital
- Noroxin
- Floxin
- Cipro · Bayer AG
- Levaquin · Generic (originally Daiichi Sankyo/J&J)
Levofloxacin is a fluoroquinolone antibacterial agent. - Ofloxacine · Assistance Publique - Hôpitaux de Paris
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Bacterial Corneal Ulcer Infection patent landscape — cliff calendar, originator estates, attackable patents
- Bacterial Corneal Ulcer Infection treatment landscape brief
- Bacterial Corneal Ulcer Infection treatment updates RSS
Frequently asked questions about Bacterial Corneal Ulcer Infection
What drugs treat Bacterial Corneal Ulcer Infection?
Tracked treatments include Ciprofloxacine, Noroxin, Floxin, Cipro, Levaquin, Ofloxacine.
What is the treatment for Bacterial Corneal Ulcer Infection?
Standard treatment for Bacterial Corneal Ulcer Infection includes Ciprofloxacine, Noroxin, Floxin, Cipro, Levaquin. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Bacterial Corneal Ulcer Infection patent cliff · Bacterial Corneal Ulcer Infection CI report
- Treatment: Ciprofloxacine · Poitiers University Hospital
- Treatment: Noroxin
- Treatment: Floxin
- Treatment: Cipro · Bayer AG
- Treatment: Levaquin · Generic (originally Daiichi Sankyo/J&J)
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing